Technique | Local anesthetics | <3 months age | 3 to 6 months age | >12 months of age | Maximum dose |
Caudal block, single injection | Ropivacaine 0.2% | 2 mg/kg | 2.5 mg/kg | 2.5 to 3 mg/kg | 3 mg/kg |
Bupivacaine 0.25% | 2 mg/kg | 2.5 mg/kg | 2.5 mg/kg | 2.5 mg/kg | |
Levobupivacaine 0.25% | 2 mg/kg | 2.5 mg/kg | 2.5 mg/kg | 2.5 mg/kg | |
2-Chloroprocaine 1.5 to 3% | 30 mg/kg | 30 mg/kg | 30 mg/kg | 30 mg/kg | |
Awake caudal anesthesia* | Ropivacaine 0.375% | 3.75 mg/kg | N/A | N/A | |
Bupivacaine 0.25% | 3.75 mg/kg | N/A | N/A | ||
Levobupivacaine 0.25% | 3.75 mg/kg | N/A | N/A | ||
2-Chloroprocaine 1.5 to 3% | 30 mg/kg, followed by infusion of 1.5% at 6.75 to 45 mg/kg/hour | N/A | N/A | ||
Caudal epidural infusion | Ropivacaine 0.1 to 0.2% | 0.2 mg/kg/hour | 0.3 mg/kg/hour | 0.4 mg/kg/hour | |
Bupivacaine 0.1 to 0.125% | 0.2 mg/kg/hour | 0.2 to 0.3 mg/kg/hour | 0.2 to 0.4 mg/kg/hour | ||
Levobupivacaine 0.1 to 0.125% | 0.2 mg/kg/hour | 0.2 to 0.3 mg/kg/hour | 0.2 to 0.4 mg/kg/hour | ||
2-Chloroprocaine 1.5 to 3% | 3.5 mg/kg/hour | 6.75 mg/kg/hour | 15 mg/kg/hour | ||
Adjuncts | |||||
Agent | Dose | Comments | |||
Opioids | |||||
Morphine |
| Pruritus is common; delayed respiratory depression possible | |||
Fentanyl |
| Not shown to increase duration of block | |||
Sufentanil |
| Not shown to increase duration of block | |||
Hydromorphone |
| ||||
Others | |||||
Clonidine |
| Sedation, bradycardia, and hypotension possible at higher doses Apnea may occur in infants <3 months of age | |||
Epinephrine |
| Biphasic reduction in absorption of local anesthetic from the epidural space |
This table shows the drugs that are commonly used for caudal block in children. Doses are based on those that have appeared in the literature. The total dose of local anesthetic, including other routes of administration, should remain within the maximum allowable doses to minimize the risk of local anesthetic toxicity.
Other adjuncts have been used for caudal block, but efficacy and lack of neurotoxicity have not been proven and their use has not received regulatory approval for children in the United States. These include ketamine, S-Ketamine, dexmedetomidine, dexamethasone, midazolam, neostigmine, and buprenorphine. For further information refer to UpToDate content on caudal block.